Basic Medical Sciences
The Department of Basic Medical Sciences (BMS) offers graduate programs leading to the Master of Science and Doctor of Philosophy degrees.
Integrative Studies for Animal and Human Health
Discovery activities range from studies of molecular and cellular processes to studies of the whole animal, in areas of cell and tissue growth, differentiation, regeneration, and numerous aspects of cancer biology. BMS faculty currently have active research programs in the areas of cancer biology; musculoskeletal biomechanics and skeletal adaptation; neural development, mechanisms of injury and regeneration; tissue dynamic spectroscopy; cellular and molecular screening; and high throughput analysis of cell function. Our directory of faculty research interests describes in more detail the exciting research that is conducted in BMS.
BMS
Department Info
Graduate Program
Cutting-edge research opportunities
Research Specialties
What we're working on
Employment Opportunities
Work with us
BMS Directory
Find our people
News
The latest headlines
Contact Us
Get in touch
Featured Faculty
Pradip Bajgain, PhD
Assistant Professor
Dr. Bajgain is a tenure-track Assistant-Professor in the Department of Basic Medical Sciences in the College of Veterinary Medicine at Purdue University. He received his BS in Molecular Biology from Brigham Young University before starting his formal training in cancer immunology and immunotherapy at Baylor College of Medicine as a research assistant first and later as a graduate student. Dr. Bajgain earned his PhD in Translational Biology and Molecular Medicine in 2019 from Baylor, where his research centered on enhancing the potency of engineered T cell therapies for cancer at the Center for Cell and Gene Therapy. Dr. Bajgain completed his postdoctoral fellowship at the National Cancer Institute in 2025, where he developed novel chimeric antigen receptor (CAR)-based strategies to target solid tumors. At Purdue, Dr. Bajgain leads a research program focused on addressing some of the key challenges that have restricted the success of engineered immune-cell therapies against solid tumors. Outside of research and teaching, Dr. Bajgain enjoys spending spare time outdoors.